A New Kind of Life Sciences Law Firm
Big Firm Expertise Priced Right
World-class biopharma IP litigation & strategy at a sensible cost.
Law firms and in-house counsel have mastered the use of remote-work tools to handle even the most complex legal challenges. This fundamental, global transformation in the legal workplace has created an unprecedented opportunity to lower the high cost of traditional “big firm” IP legal services in the U.S. Gemini was created to exploit this opportunity.
Substantial Cost Savings
Our innovative approach can lower costs by 50% or more
Our lawyers, who are among the most experienced and successful at helping manufacturers of biotech, biosimilar, biobetter, generic and 505(b)(2) products navigate IP barriers to access the U.S. market, work remotely with very little overhead. We pass the savings onto our clients.
Big Firm Infrastructure Only When Needed
We partner with big firms when needed to handle the most complex litigation.
Where “big firm” infrastructure provides a tactical advantage, such as complex district court patent infringement trials, our collaborations with top AmLaw 50 firms enable us to offer seamless, fully-integrated trial teams and budgets that leverage lower-cost Gemini resources as much as possible.
What we offer
Strategies to reduce or eliminate IP litigation risk
Biosimilar (BPCIA) & Hatch -Waxman litigation
Biotech and 505(b)(2) litigation
USPTO and PTAB Challenges
Virtual in-house counsel services
IP-related corporate transactions
Strategic patent prosecution & portfolio optimization
We are here to help any time, any time zone.
With lawyers based in the U.S. and Asia, we are available during your business day no matter where your business is.